Vivo Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,329,509
| Closed | -$183M | – | 54 |
|
|
2022
Q2 | $183M | Sell |
3,329,509
-2
| -0% | -$105 | 18.38% | 2 |
|
|
2022
Q1 | $107M | Buy |
3,329,511
+1,412,437
| +74% | +$40.5M | 7.35% | 5 |
|
|
2021
Q4 | $41.7M | Hold |
1,917,074
| – | – | 2.51% | 10 |
|
|
2021
Q3 | $42M | Hold |
1,917,074
| – | – | 1.89% | 12 |
|
|
2021
Q2 | $37.3M | Hold |
1,917,074
| – | – | 1.62% | 16 |
|
|
2021
Q1 | $33M | Hold |
1,917,074
| – | – | 1.16% | 20 |
|
|
2020
Q4 | $30.7M | Hold |
1,917,074
| – | – | 1.37% | 17 |
|
|
2020
Q3 | $20.5M | Hold |
1,917,074
| – | – | 1.18% | 21 |
|
|
2020
Q2 | $23.2M | Hold |
1,917,074
| – | – | 1.66% | 16 |
|
|
2020
Q1 | $18.8M | Buy |
+1,917,074
| New | +$25.1M | 1.71% | 15 |
|
|
2019
Q3 | – | Sell |
-60,957
| Closed | -$1.36M | – | 42 |
|
|
2019
Q2 | $1.36M | Hold |
60,957
| – | – | 0.13% | 42 |
|
|
2019
Q1 | $4.17M | Hold |
60,957
| – | – | 0.42% | 40 |
|
|
2018
Q4 | $3.22M | Hold |
60,957
| – | – | 0.41% | 33 |
|
|
2018
Q3 | $4.14M | Hold |
60,957
| – | – | 0.42% | 36 |
|
|
2018
Q2 | $7.22M | Hold |
60,957
| – | – | 0.93% | 25 |
|
|
2018
Q1 | $5.05M | Hold |
60,957
| – | – | 0.72% | 23 |
|
|
2017
Q4 | $9.1M | Hold |
60,957
| – | – | 1.95% | 16 |
|
|
2017
Q3 | $3.78M | Hold |
60,957
| – | – | 0.76% | 23 |
|
|
2017
Q2 | $2.85M | Hold |
60,957
| – | – | 0.72% | 20 |
|
|
2017
Q1 | $3.73M | Hold |
60,957
| – | – | 1.1% | 16 |
|
|
2016
Q4 | $3.63M | Hold |
60,957
| – | – | 1.2% | 17 |
|
|
2016
Q3 | $4.44M | Hold |
60,957
| – | – | 1.38% | 15 |
|
|
2016
Q2 | $4.85M | Hold |
60,957
| – | – | 1.33% | 15 |
|
|
2016
Q1 | $16.4M | Buy |
+60,957
| New | +$19.5M | 4.12% | 8 |
|
Other funds holding SRRA
Vivo Capital's SRRA Position: Q3 2022 in Review
Vivo Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 3,329,509 shares — an estimated $183M sold.
Vivo Capital first reported a position in SRRA in Q1 2016 and held it in 24 quarters. The position peaked at $183M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Vivo Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Vivo Capital sold 3,329,509 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $183M.
- Vivo Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 24 quarters.
- Vivo Capital's Sierra Oncology, Inc. Common Stock position peaked at $183M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Vivo Capital's 13F filing for Q3 2022, filed 14 Nov 2022.